Carl Zeiss Meditec AG (ETR:AFX)

Carl Zeiss Meditec AG Balance Sheet

Financials in millions EUR. Fiscal year is October - September.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	23.9	27.27	20.29	10.6	7.73	7.44
Cash & Short-Term Investments	23.9	27.27	20.29	10.6	7.73	7.44
Cash Growth	-9.99%	34.42%	91.35%	37.16%	3.90%	19.95%
Accounts Receivable	453.69	520.82	438.12	421.45	414.28	320.81
Other Receivables	170.02	170.86	144.82	875.7	912.18	953.5
Total Trade Receivables	623.7	691.68	582.94	1,297	1,326	1,274
Inventory	538.55	497.21	536.56	520.23	382.75	286.38
Other Current Assets	46.64	64.14	72.71	83.75	74.92	35.9
Total Current Assets	1,233	1,280	1,212	1,912	1,792	1,604
Net Property, Plant & Equipment	336.14	342.95	353.76	315.77	236.15	199.56
Other Intangible Assets	632.45	662.87	706.85	259.49	240.43	153.7
Goodwill	975.6	969.74	982.51	415.78	429.65	328.71
Long-Term Investments	36.18	28.93	20.38	21.46	10.83	6.71
Other Long-Term Assets	125.37	118.58	117.22	108.7	113.92	103.27
Total Assets	3,339	3,403	3,393	3,033	2,823	2,396

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Accounts Payable	185.6	194.1	183.54	239.79	189.19	145.47
Accrued Expenses	134.41	194.7	194.04	176.27	164.27	147.66
Short-Term Debt	36.6	19.55	19.11	24.18	66.88	54.94
Current Portion of Leases	23.22	24.14	24.59	21.82	21.59	19.34
Other Current Liabilities	128.38	111.32	147.56	99.59	97.4	80.71
Total Current Liabilities	508.22	543.81	568.84	561.65	539.32	448.12
Long-Term Debt	455.24	455.36	458.9	96.03	91.77	76.5
Long-Term Leases	102.49	108.32	126.76	133.88	106.32	101.93
Other Long-Term Liabilities	164.51	168.19	182.23	68.47	55.32	92.04
Total Long-Term Liabilities	722.24	731.86	767.89	298.38	253.41	270.47
Total Liabilities	1,230	1,276	1,337	860.02	792.73	718.59

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Common Stock	89.44	89.44	89.44	89.44	89.44	89.44
Treasury Stock	-150.08	-150.08	-150.08	0	-	-
Additional Paid-in Capital	620.14	620.14	620.14	620.14	620.14	620.14
Accumulated Other Comprehensive Income	-2.42	-18.11	-4.23	43.97	91.63	-50.73
Retained Earnings	1,542	1,575	1,486	1,406	1,214	1,000
Total Common Shareholders' Equity	2,099	2,117	2,042	2,159	2,015	1,659
Minority Interest	9.36	11.19	14.78	13.45	14.99	18.06
Shareholders' Equity	2,108	2,128	2,056	2,173	2,030	1,677
Total Liabilities & Equity	3,339	3,403	3,393	3,033	2,823	2,396

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Total Debt	617.56	607.37	629.35	275.91	286.55	252.71
Net Cash (Debt)	-593.66	-580.1	-609.07	-265.31	-278.83	-245.27
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-6.78	-6.63	-6.86	-2.97	-3.12	-2.74
Book Value	2,099	2,117	2,042	2,159	2,015	1,659
Book Value Per Share	23.98	24.18	22.98	24.14	22.53	18.55
Tangible Book Value	490.67	483.89	352.34	1,484	1,345	1,177
Tangible Book Value Per Share	5.61	5.53	3.97	16.59	15.04	13.16

Data Source: Fiscal.ai Last updated: Jul 1, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 12, 2026

Data Sources Report a data error